New Antitrichomonal Drug-like Chemicals Selected by Bond (Edge)-Based TOMOCOMD-CARDD Descriptors
暂无分享,去创建一个
Francisco Torrens | Yovani Marrero-Ponce | Ricardo Grau | Alfredo Meneses-Marcel | José Antonio Escario | Juan José Nogal | Vicente J. Arán | Froylán Ibarra-Velarde | Y. Marrero-Ponce | R. Grau | F. Torrens | Alfredo Meneses-Marcel | Yanetsy Machado Tugores | J. Nogal | J. Escario | F. Ibarra-Velarde | V. Arán | A. Montero | O. Rivera-Borroto | V. Kouznetsov | A. R. Bohórquez | Alina Montero | Oscar M. Rivera-Borroto | Yanetsy Machado Tugores | Alicia Gómez Barrio | David Montero Pereira | Vladimir V. Kouznetsov | Cristian Ochoa Puentes | Arnold R. Bohórquez | David Montero Pereira | A. Gómez Barrio | Cristian Ochoa Puentes
[1] C. Livengood,et al. RESOLUTION OF RESISTANT VAGINAL TRICHOMONIASIS ASSOCIATED WITH THE USE OF INTRA VAGINAL NONOXYNOL‐9 , 1991, Obstetrics and gynecology.
[2] Charles E. Heckler,et al. Applied Multivariate Statistical Analysis , 2005, Technometrics.
[3] J. K. Sugden,et al. Chemotherapy of amoebiasis. , 1976, Pharmaceutica acta Helvetiae.
[4] W. Secor,et al. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis , 1996, Antimicrobial agents and chemotherapy.
[5] E. Graf. Organic-chemical drugs and their synonyms (an international survey), 6th revised and enlarged edit. Von M. Negwer; Akademie-Verl. Berlin; VCH Publishers, Inc. New York 1978. 3 Vol's, 2470 S., geb. DM 320,– , 1990 .
[6] Ernesto Estrada,et al. A novel approach for the virtual screening and rational design of anticancer compounds. , 2000, Journal of medicinal chemistry.
[7] R. Marcos,et al. Genotoxic evaluation of the furylethylene derivative 2-furyl-1-nitroethene in cultured human lymphocytes. , 2001, Mutation research.
[8] P. Wilson,et al. Povidone‐Iodine in the Treatment of Metronidazole‐Resistant Trichomonas vaginalis , 1990, The Australian & New Zealand journal of obstetrics & gynaecology.
[9] A. Kearns,et al. Failure of mebendazole to cure trichomonal vaginitis resistant to metronidazole: case reports. , 1989, Genitourinary medicine.
[10] Jesús Vicente de Julián-Ortiz,et al. Topological Approach to Drug Design , 1995, J. Chem. Inf. Comput. Sci..
[11] S. Unger. Molecular Connectivity in Structure–activity Analysis , 1987 .
[12] E Uriarte,et al. Recent advances on the role of topological indices in drug discovery research. , 2001, Current medicinal chemistry.
[13] Jorge Gálvez,et al. Charge Indexes. New Topological Descriptors , 1994, J. Chem. Inf. Comput. Sci..
[14] E. Stashenko,et al. Synthesis and Antiparasitic Properties of New 4‐N‐Benzylamino‐4‐Hetarylbut‐1‐enes , 2005, Archiv der Pharmazie.
[15] Daniel Vitt,et al. Virtual high-throughput in silico screening , 2003 .
[16] P. Nyirjesy,et al. Paromomycin for nitroimidazole-resistant trichomonosis , 1995, The Lancet.
[17] A. Hagler,et al. Chemoinformatics and Drug Discovery , 2002, Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry.
[18] P. Nyirjesy,et al. Difficult-to-treat trichomoniasis: results with paromomycin cream. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] Richard K. Scott. Informatics integration: the bedrock of NCE selection , 2003 .
[20] K. Workowski,et al. Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] E. Gavini,et al. Synthesis and “in Vitro” Antimicrobial Properties of N‐Oxide Derivatives Based on Tricyclic Indeno[2,1‐c]pyridazine and Benzo[f]cinnoline Systems , 2000, Archiv der Pharmazie.
[22] G. Burstein,et al. Sexually transmitted diseases treatment guidelines , 2003, Current opinion in pediatrics.
[23] E. Houang,et al. Successful Treatment of Four Patients With Recalcitrant Vaginal Trichomoniasis With a Combination of Zinc Sulfate Douche and Metronidazole Therapy , 1997, Sexually transmitted diseases.
[24] Facundo Pérez-Giménez,et al. Discrimination and Molecular Design of New Theoretical Hypolipaemic Agents Using the Molecular Connectivity Functions , 2000, J. Chem. Inf. Comput. Sci..
[25] S. Wold,et al. Statistical Validation of QSAR Results , 1995 .
[26] Yovani Marrero-Ponce,et al. Bond-based global and local (bond, group and bond-type) quadratic indices and their applications to computer-aided molecular design. 1. QSPR studies of diverse sets of organic chemicals , 2006, J. Comput. Aided Mol. Des..
[27] R. Marcos,et al. In vitro genotoxicity testing of the furylethylene derivative UC-245 in human cells. , 2004, Mutagenesis.
[28] R. Pattman,et al. Arsenical pessaries in the successful elimination of metronidazole-resistant Trichomonas vaginalis , 1996, International journal of STD & AIDS.
[29] Han van de Waterbeemd,et al. Chemometric Methods in Molecular Design: van de Waterbeemd/Chemometric , 1995 .
[30] Pierre Baldi,et al. Assessing the accuracy of prediction algorithms for classification: an overview , 2000, Bioinform..
[31] Mahabir P. Gupta,et al. A Straightforward Synthetic Approach to Antitumoral Pyridinyl Substituted 7H-Indeno[2,1-c]Quinoline Derivatives Via Three-Component Imino Diels- Alder Reaction , 2006 .
[32] Han van de Waterbeemd,et al. Chemometric methods in molecular design , 1995 .
[33] Christopher Watson. Predictive in silico models in drug discovery , 2003 .
[34] V. Kouznetsov,et al. 4‐Aryl(benzyl)amino‐4‐heteroarylbut‐1‐enes as Building Blocks in Heterocyclic Synthesis. 4.1 Synthesis of 4, 6‐Dimethyl‐5‐nitro(amino)‐2‐pyridylquinolines and their Antiparasitic Activities , 2004, Archiv der Pharmazie.
[35] J. Mcgregor,et al. Trichomonas Vaginalis: A Reemerging Pathogen , 1993, Clinical obstetrics and gynecology.